Home/Filings/4/0000950103-21-010245
4//SEC Filing

Reddoch James F. 4

Accession 0000950103-21-010245

CIK 0001802768other

Filed

Jul 7, 8:00 PM ET

Accepted

Jul 8, 7:37 PM ET

Size

18.3 KB

Accession

0000950103-21-010245

Insider Transaction Report

Form 4
Period: 2021-07-06
Reddoch James F.
EVP, Research & Investments
Transactions
  • Sale

    Class A Ordinary Shares

    2021-07-06$42.40/sh30,270$1,283,5601,240,530 total(indirect: By LLC)
  • Sale

    Class A Ordinary Shares

    2021-07-07$42.01/sh2,192$92,0871,238,338 total(indirect: By LLC)
  • Sale

    Class A Ordinary Shares

    2021-07-08$42.05/sh40,655$1,709,3801,197,683 total(indirect: By LLC)
Holdings
  • Class A Ordinary Shares

    (indirect: By IRA)
    25,030
Footnotes (3)
  • [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.82 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.21 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Royalty Pharma plc

CIK 0001802768

Entity typeother

Related Parties

1
  • filerCIK 0001814872

Filing Metadata

Form type
4
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 7:37 PM ET
Size
18.3 KB